GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sailong Pharmaceutical Group Co Ltd (SZSE:002898) » Definitions » Interest Coverage

Sailong Pharmaceutical Group Co (SZSE:002898) Interest Coverage : 0.68 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Sailong Pharmaceutical Group Co Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Sailong Pharmaceutical Group Co's Operating Income for the three months ended in Mar. 2025 was ¥1.2 Mil. Sailong Pharmaceutical Group Co's Interest Expense for the three months ended in Mar. 2025 was ¥-1.8 Mil. Sailong Pharmaceutical Group Co's interest coverage for the quarter that ended in Mar. 2025 was 0.68. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Sailong Pharmaceutical Group Co's Interest Coverage or its related term are showing as below:


SZSE:002898's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 119.89
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Sailong Pharmaceutical Group Co Interest Coverage Historical Data

The historical data trend for Sailong Pharmaceutical Group Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Sailong Pharmaceutical Group Co Interest Coverage Chart

Sailong Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.69 -

Sailong Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.50 2.65 - - 0.68

Competitive Comparison of Sailong Pharmaceutical Group Co's Interest Coverage

For the Biotechnology subindustry, Sailong Pharmaceutical Group Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sailong Pharmaceutical Group Co's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sailong Pharmaceutical Group Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Sailong Pharmaceutical Group Co's Interest Coverage falls into.


;
;

Sailong Pharmaceutical Group Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sailong Pharmaceutical Group Co's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Sailong Pharmaceutical Group Co's Interest Expense was ¥-6.7 Mil. Its Operating Income was ¥-7.7 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥30.2 Mil.

Sailong Pharmaceutical Group Co did not have earnings to cover the interest expense.

Sailong Pharmaceutical Group Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Here, for the three months ended in Mar. 2025, Sailong Pharmaceutical Group Co's Interest Expense was ¥-1.8 Mil. Its Operating Income was ¥1.2 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥29.4 Mil.

Interest Coverage=-1* Operating Income (Q: Mar. 2025 )/Interest Expense (Q: Mar. 2025 )
=-1*1.189/-1.759
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Sailong Pharmaceutical Group Co  (SZSE:002898) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Sailong Pharmaceutical Group Co Interest Coverage Related Terms

Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Sailong Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 47, Haibin South Road, 2nd Floor, Everbright International Trade Center, Guangdong Province, Zhuhai, CHN, 519015
Sailong Pharmaceutical Group Co Ltd is a pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.
Executives
Tang Lin Director
Long Zhi Xiang Director
Deng Yong Jun Supervisors
Zhou Bei Supervisors
Li Jian Feng Directors, executives

Sailong Pharmaceutical Group Co Headlines

No Headlines